LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹101 Cr | ₹101 Cr | ₹90 Cr | ₹88 Cr | ₹84 Cr |
What is the latest Total Liabilities ratio of LACTOSE (INDIA) ?
| Year | Total Liabilities |
|---|---|
| Mar2024 | ₹101 Cr |
| Mar2023 | ₹101 Cr |
| Mar2022 | ₹90 Cr |
| Mar2021 | ₹88 Cr |
| Mar2020 | ₹84 Cr |
How is Total Liabilities of LACTOSE (INDIA) Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹101 Cr | -0.54 | |
| Mar2023 | ₹101 Cr | 12.27 | |
| Mar2022 | ₹90 Cr | 2.13 | |
| Mar2021 | ₹88 Cr | 5.17 | |
| Mar2020 | ₹84 Cr | - | |
Compare Total Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹142.4 Cr | -2.2% | -9.5% | -32.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,147.0 Cr | -1.4% | 3.6% | -7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,488.0 Cr | 4.4% | 15.9% | 15.6% | Stock Analytics | |
| CIPLA | ₹121,452.0 Cr | -4.9% | -0.8% | 6.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,057.0 Cr | -0.6% | 1.8% | 15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,220.0 Cr | -4.1% | -3.8% | -4.3% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -2.2% |
-9.5% |
-32.1% |
| SENSEX | -1.4% |
3.1% |
3.8% |
You may also like the below Video Courses